Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ABOBOTULINUMTOXINA Cause Drug ineffective? 1,677 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 1,677 reports of Drug ineffective have been filed in association with ABOBOTULINUMTOXINA. This represents 29.0% of all adverse event reports for ABOBOTULINUMTOXINA.

1,677
Reports of Drug ineffective with ABOBOTULINUMTOXINA
29.0%
of all ABOBOTULINUMTOXINA reports
0
Deaths
5
Hospitalizations

How Dangerous Is Drug ineffective From ABOBOTULINUMTOXINA?

Of the 1,677 reports, 5 (0.3%) required hospitalization, and 1 (0.1%) were considered life-threatening.

Is Drug ineffective Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ABOBOTULINUMTOXINA. However, 1,677 reports have been filed with the FAERS database.

What Other Side Effects Does ABOBOTULINUMTOXINA Cause?

Off label use (2,271) Product preparation error (751) Headache (379) Overdose (344) Inappropriate schedule of drug administration (318) Therapeutic response shortened (313) Eyelid ptosis (301) Injection site pain (278) Muscular weakness (272) Intentional product misuse (259)

What Other Drugs Cause Drug ineffective?

ADALIMUMAB (71,926) METHOTREXATE (70,142) ETANERCEPT (60,367) ADAPALENE (52,181) ABATACEPT (35,212) INFLIXIMAB (33,738) TOCILIZUMAB (32,342) RITUXIMAB (32,186) LEFLUNOMIDE (31,396) HYDROXYCHLOROQUINE (31,057)

Which ABOBOTULINUMTOXINA Alternatives Have Lower Drug ineffective Risk?

ABOBOTULINUMTOXINA vs ABRAXANE ABOBOTULINUMTOXINA vs ABROCITINIB ABOBOTULINUMTOXINA vs ACALABRUTINIB ABOBOTULINUMTOXINA vs ACAMPROSATE ABOBOTULINUMTOXINA vs ACARBOSE

Related Pages

ABOBOTULINUMTOXINA Full Profile All Drug ineffective Reports All Drugs Causing Drug ineffective ABOBOTULINUMTOXINA Demographics